Locally Advanced and Inflammatory Breast Cancer
- 10 February 2008
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (5) , 786-790
- https://doi.org/10.1200/jco.2008.15.0243
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 TrialJournal of Clinical Oncology, 2007
- Monitoring primary breast cancer throughout chemotherapy using FDG-PETBreast Cancer Research and Treatment, 2006
- Flare in Neuropathy Following Rituximab Therapy for Waldenstrom’s MacroglobulinemiaJournal of Clinical Oncology, 2006
- Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trialAnnals of Oncology, 2005
- Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray AnalysisBreast Cancer Research and Treatment, 2005
- Evolving Treatment Strategies for Inflammatory Breast Cancer: A Population-Based Survival AnalysisJournal of Clinical Oncology, 2005
- Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast CancerCancer Research, 2005
- Adjuvant therapy of breast cancer: The Southwest Oncology Group experienceBreast Cancer Research and Treatment, 1983
- Inflammatory carcinoma of the breastCancer, 1978
- Inflammatory Carcinoma of the BreastAnnals of Surgery, 1976